Trial on Statins for Cirrhosis Won't End Debate Anytime Soon
(MedPage Today) -- Statin therapy delivered a statistical near miss at lowering risks of hepatic decompensation and liver cancer in patients with compensated cirrhosis, the phase III SACRED trial showed. In an intention-to-treat analysis, 8.97...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.